The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade
- PMID: 2459516
The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade
Abstract
The alpha 1-adrenergic receptor blocking effect of ketanserin, the blocking properties of this compound for nonspecific stimulation with angiotensin II, and the alpha-adrenergic receptor blocking properties and the blood pressure lowering effect of phentolamine, ritanserin, and the combination of both compounds were studied in patients on cardiopulmonary bypass (constant flow rate, mild hypothermia) undergoing coronary artery bypass grafting. Phenylephrine was used as alpha 1-adrenergic agonist. Ketanserin reduces the alpha 1-agonistic effect of phenylephrine on blood pressure in a dose-dependent manner up to a dose of 10 mg. Ketanserin did not block the nonspecific vasoconstriction, as induced by angiotensin II. The moderate blood pressure lowering effect of phentolamine was substantially potentiated by ritanserin, which in itself did not affect blood pressure. The findings in this study indicate that the blood pressure lowering activity of ketanserin results from a combined blockade of alpha 1-adrenergic and S2-serotonergic receptors.
Similar articles
-
5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.J Cardiovasc Pharmacol. 1988;11 Suppl 1:S25-9. J Cardiovasc Pharmacol. 1988. PMID: 2459510
-
Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.J Cardiovasc Pharmacol. 1988;11 Suppl 1:S22-4. J Cardiovasc Pharmacol. 1988. PMID: 2459509
-
Are there interactions between S2-serotonergic and alpha 1-adrenergic receptors in isolated canine arteries?J Cardiovasc Pharmacol. 1988;11 Suppl 1:S16-21. J Cardiovasc Pharmacol. 1988. PMID: 2459508
-
Antihypertensive properties of ketanserin (R 41 468).Fed Proc. 1983 Feb;42(2):182-5. Fed Proc. 1983. PMID: 6295821 Review.
-
Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.J Cardiovasc Pharmacol. 1988;11 Suppl 1:S10-5. J Cardiovasc Pharmacol. 1988. PMID: 2459506 Review.
Cited by
-
5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin.Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:59-61. doi: 10.1007/BF00053428. Cardiovasc Drugs Ther. 1990. PMID: 2285652
-
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010. Drugs. 1990. PMID: 2079001 Review.
-
Serotonin and acute cardiovascular disorders.Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:19-25. doi: 10.1007/BF00053422. Cardiovasc Drugs Ther. 1990. PMID: 2285646 Review.
-
Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.Eur J Clin Pharmacol. 1993;44(2):121-5. doi: 10.1007/BF00315468. Eur J Clin Pharmacol. 1993. PMID: 8453957
-
High and Hyper: Fentanyl Induces Psychomotor Side-Effects in Healthy Pigs.Animals (Basel). 2023 May 17;13(10):1671. doi: 10.3390/ani13101671. Animals (Basel). 2023. PMID: 37238100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources